Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Drones delivered defibrillators to patients with suspected cardiac arrests

Researchers at Karolinska Institutet in Sweden can now report the results of a unique pilot project where drones were used to deliver defibrillators to real-life alerts of suspected cardiac arrest. The drones were dispatched in more than a fifth of the emergencies and arrived on target and ahead of the ambulance in most cases. The results are published in the European Heart Journal and presented today at the European Society of Cardiology congress.”This is the first time in the world that a research group can report results from a study where drones flew defibrillators to location of real-

Dooba Finance AB (publ) – Publishing of the Quarter End Report for Q2 2021

On 27 October 2020, Dooba Finance AB (publ) (the “Company”) issued senior unsecured bonds in an amount of SEK 500.5 million guaranteed by Dooba Holdings Limited (the “Bonds”). On 22 March 2021, Dooba Finance AB (publ) (the “Company”) issued senior unsecured bonds in an amount of SEK 99 million under its existing framework of up to SEK 600 million senior unsecured bonds due 2024 (ISIN: NO0010895360) (the “Subsequent Bonds”).The Company today announces the publication of its Quarter End Report for Q2 2021. The report can be found at https://dfabbond.se/

Prostatype Genomics AB intends to carry out a directed share issue of approximately SEK 24 million

- Prostatype Genomics AB (“Prostatype” or “the Company”) hereby announces that the Company intends to carry out a directed share issue of approximately SEK 24 million to Swedish and international investors. The Company has assigned Sedermera Fondkommission to act as bookrunner in connection with the directed share issue. The capital raise is intended to finance activities carried out within the previously announced agreement with Proteomedix AG (“Proteomedix”).Cooperation with Proteomedix Proteomedix develops a next generation blood test for prostate cancer. The product complements

Prostatype Genomics AB enters into cooperation with leading actor in the prostate cancer area

– Agreement on marketing and R&D cooperation enhancing market position short- and long-termProstatype Genomics AB (“Prostatype Genomics”) has signed a cooperation agreement with Proteomedix AG (“Proteomedix”), a Zurich based science-driven company that has an approved product in the field of prostate cancer. The product is complementary to Prostatype®, the gene based prognostic tool developed and marketed by Prostatype Genomics. Used in different stages of the clinical process of prostate cancer, Prostatype® and the complementary product this will offer unique decision support for

Norway Royal Salmon ASA (NRS): Final result in mandatory offer to acquire all shares in Norway Royal Salmon ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFULThis is a copy of the stock exchange announcement from NTS ASA of 26 August 2021 on ticker "NTS" Reference is made to the offer document dated 16 July 2021 (the "Offer Document") prepared in connection with the mandatory offer to purchase all remaining shares in Norway Royal Salmon ASA ("NRS") not already owned by NTS ASA (the “Offeror” or "NTS"),

Allocation of warrants to CEO and a key employee

Today, LED iBond International A/S’ board of directors has decided to issue warrants to its CEO and a key employee of the company’s subsidiary LED iBond A/S.The warrants are issued on the following terms: · 1,500 warrants are issued to the CEO of LED iBond International A/S and 1,000 warrants to the key employee of LED iBond A/S. · The warrants carry the right to subscribe for up to 50,000 new shares in the company at a nominal value of DKK 0.05 per share. · The warrants will vest over 24 months with 1/24 per month. · The strike price upon exercise is DKK 8.10 per share of DKK

Interim report for the second quarter and first half of 2021

Half-year revenue up 81 %, solid pipeline,revised financial outlook due to COVID-19Today, LED iBond International’s (LED iBond) Board of Directors approved the interim report for the second quarter (Q2) of 2021. Highlights of the report include: Business development · In general, LED iBond’s sales pipeline is solid and grows at a steady pace. · Vertical farming: The vertical farming market, in particular, is showing continued strong growth. LED iBond has received a substantial number of requests for proposals for lighting solutions for indoor farming projects. The company has

MUSTI GROUP PLC: Share Repurchase 26.8.2021

Musti Group Stock Exchange Release 26.8.2021 MUSTI GROUP PLC: Share Repurchase 26.8.2021 In the NASDAQ OMX Helsinki Trade date           26.8.2021Bourse trade         BuyShare                  MUSTIAmount             7 000 SharesAverage price/ share    33,9641 EURTotal cost            237 748,70 EUR Company now holds a total of 244 000 sharesincluding the shares repurchased on 26.8.2021 On behalf of Musti Group Nordea Bank Finland Plc Janne Sarvikivi

ODI Pharma AB: Publication of year-end report for the financial year 2020/2021

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the fourth quarter and financial year 1[st] of July 2020 – 30[th] of June 2021. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Fourth quarter (2021-04-01 – 2021-06-30) The Group's net sales amounted to SEK 0 (-218 520). The Group's loss after financial items amounted to SEK -1,886,158 (-1,229,862). Result per share amounted to SEK -0.12 (-0.08).* The solidity as of 2021-06-30 was 96.55 % (96.23).*

Publication of a Prospectus

26 August 2021 International Personal Finance plc Publication of Prospectus The following prospectus (the "Prospectus") has been approved by the Financial Conduct Authority and is available for viewing: Prospectus dated 26 August 2021 relating to the International Personal Finance plc's €1,000,000,000 Euro Medium Term Note Programme. To view the full document together with the documents incorporated by reference, please paste the following URL into the address bar of your browser: http://www.ipfin.co.uk/en/investors/debt-funding-information.html A copy of the above

Norway Royal Salmon ASA (NRS): Flagging

Reference is made to NTS ASA's («NTS») mandatory bid for all outstanding shares in Norway Royal Salomon ASA («NRS»). On 26 August 2021, Norway Fresh AS accepted the offer of NOK 240 per share, and thus sells its 4,496,708 shares in NRS. This corresponds to 10.32% of the issued shares and votes in NRS. Following the transaction, Norway Fresh AS will no longer have ownership or voting rights in NRS. The flagging is triggered because Norway Fresh AS accepts NTS's mandatory offer, and thus Norway Fresh's ownership falls below 10%.

Ji Ham New Acting CEO of EG7

The Board of Enad Global 7 AB (publ) and Robin Flodin have agreed that effective immediately Robin will transition away from his current role as CEO of EG7 and will be replaced by the current CEO of Daybreak Game Company, EG7’s largest subsidiary, Ji Ham. During this transition Robin will stay on for six months to assist Ji as he assumes his new role within the EG7 family of companies. Ji will be appointed acting CEO of EG7 as a search for a permanent CEO has been initiated. Ji has an extensive background in both gaming and finance and has for the last six years been the CEO of Daybreak.

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 26.08.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 26.08.2021 at 18:30 CEST ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 26.08.2021 Date 26.08.2021Exchange transaction BuyShare class ALEXAmount 1,677Average price/share 8.5981 EURHighest price/share 8.6300 EURLowest price/share 8.5900 EURTotal price 14,419.01 EUR The shares held by Alexandria Pankkiiriliike Oyj on 26.08.2021: ALEX 1,677 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

Nomination Committee ahead of RevolutionRace’s Annual General Meeting 2021

At the Extraordinary General Meeting of RVRC Holding AB (publ) on 15 April 2021, it was resolved that the Nomination Committee of the company ahead of the Annual General Meeting 2021 shall be composed of the representatives of the three largest shareholders in terms of voting rights, as of the last banking day in July 2021, and of the Chairman of the Board of Directors.Following contacts with the company's shareholders, the following members have been appointed to form, together with the Chairman of the Board, a Nomination Committee for the time until a new Nomination Committee has been

BerGenBio ASA: Share capital increase

Bergen, Norway, 26 August 2021 - Reference is made to the stock exchange notice published by BerGenBio ASA (the "Company") (OSE: BGBIO) on 23 August 2021 where the Company announced that the board of directors of the Company had resolved to increase the Company's share capital in connection with the exercise of options pursuant to the Company's share option program. A total of 270,000 options were exercised and 270,000 new shares were issued at an average subscription price of NOK 10.86 per share. The share capital increase has been duly registered in the Norwegian Register of Business

Lifco issues bond loan of SEK 750 million

Lifco  has issued an unsecured bond loan with a tenor of two years within its MTN program (Medium Term Notes). The bond loan amounts to SEK 750 million with maturity on 6 September 2023 and carries a floating interest rate of three months STIBOR +0.53% annually. The bond generated strong investor interest. The proceeds from the bond issue will be used for refinancing of existing bank loans. Lifco intends to list the new bonds on the corporate bond list of Nasdaq Stockholm. Danske Bank and SEB acted as lead banks for the issuance. For more information please

Seadrill New Finance Limited (the “Issuer”) - Seabras JV Fleet Status Report

Hamilton, Bermuda, August 26, 2021 – Seadrill Limited ("Seadrill" or "the Company") (OSE:SDRL, OTCPK:SDRLF) and the Issuer announce the publication of a Fleet status report for the Seabras Sapura JV.  FORWARD LOOKING STATEMENTS This news release includes forward looking statements. Such statements are generally not historical in nature, and specifically include statements about the Company's plans, strategies, business prospects, changes and trends in its business, the markets in which it operates and its restructuring efforts. These statements are made based upon management's current

#21-284 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Adapteo Plc: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Adapteo Plc Regulatory press release 26 August 2021 at 16:45 CEST Adapteo Plc (the "Company") has received on 25 August 2021 the following notification pursuant to Chapter 9, Section 5 of the Securities Markets Act (the "SMA") from Sterling Strategic Value Fund S.A., SICAV-RAIF. According to the notification, the holding in the Company's shares and votes of Sterling Strategic Value Fund S.A., SICAV-RAIF has fallen below the threshold of five (5) per cent on 25 August 2021. According to the notification, the reason for the notification was a disposal of shares or voting rights.

Yaytrade signs an agreement with Gents Wear Group for the sale of outgoing stock

Ytrade Group AB (publ) ("Yaytrade" or the "Company") has today entered into an agreement with Gents Wear Group AB ("NK Studio") regarding the sale of outgoing stock. Gents Wear Group, a well-established premium store located in the Nordiska Kompaniet department store in Stockholm, has entered into a partnership with Yaytrade for the sale of outgoing stock via Yaytrade's marketplace and digital pop-up solution. "We’ve been active in the clothing industry for many years through production, sales agency operations, and retail activities. We have various locations including the NK Studio

Announcement from Systemair AB (publ) Annual General Meeting 2021

Press Release, 26 August 2021 Systemair (NASDAQ OMX Stockholm: SYSR) held its Annual General Meeting on August 26, 2021 in the Systemair Expo in Skinnskatteberg, Sweden. At the meeting, 106 voting shareholders were represented, which corresponds to 87.93% of the total number of votes and shares. The Meeting voted in favour of the Board’s and the Nomination committee’s proposal in all suggestions. The main content of the most important decisions was: Adoption of income statement and balance sheet, dividend and discharge from liability The Annual General Meeting resolved to approve

Norway Royal Salmon (NRS) - Mandatory notification of trade and disclosure of large shareholding

Reference is made to NTS ASA's («NTS») mandatory bid for all outstanding shares in Norway Royal Salmon ASA («NRS»). On 26 August 2021, Egil Kristoffersen & Sønner AS ("EKS") accepted the offer of NOK 240 per share, and thus sells its 4,577,453 shares in NRS. This corresponds to 10.51% of the issued shares and votes in NRS. After the transaction, EKS will no longer have ownership or voting rights in NRS. The flagging is triggered because EKS accepts NTS's mandatory offer, and thus EKS's ownership falls below 10%.

ContextVision: Assessing a Digital Pathology spin-off with a listing on Euronext Growth

STOCKHOLM – August 26, 2021 - ContextVision, a medical technology software company specializing in image processing and decision support tools within digital pathology, today announces that the Board of Directors of ContextVision is conducting a review of the company’s structure, and has initiated work assessing a spin-off of the Digital Pathology unit with a goal of listing the new entity on the Euronext Growth on the Oslo Stock Exchange. The review is expected to be concluded by the end of the fourth quarter 2021. ContextVision’s Board of Directors believes a split of the Company –

There are no items matching the current filter
There are no more items matching the current filter
Back to top